The reduction in hepatic fat in HIV-associated fatty liver disease, alongside the primary visceral-fat effect, has been characterized in randomized trials, and the mechanistic follow-up identified reductions in fibro-inflammatory mediators (VEGFA, TGF-1, CSF1) that track with improvements in liver-injury scores
As obesity and Type 2 Diabetes Prevalence rises globally, theres scope for strong uptake in developed and emerging markets, especially where injectable GLP-1 therapies are less accessible
This review synthesizes mechanistic insights from redox biology and immunometabolism to clinical trial data, proposing a framework for optimizing VC-based combination therapies while addressing critical gaps in biomarker development and dose scheduling
4 Gastrointestinal side effects are common but can be managed
Its also wonderful for helping with blood sugar control and as such can be a great nutrient for women with PCOS